Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Eur J Pharmacol ; 906: 174205, 2021 Sep 05.
Artigo em Inglês | MEDLINE | ID: mdl-34048740

RESUMO

The K+-Cl- co-transporter 2 (KCC2) is a neuron-specific Cl- extruder in the dorsal horn of spinal cord. The low intracellular Cl- concentration established by KCC2 is critical for GABAergic and glycinergic systems to generate synaptic inhibition. Peripheral nerve lesions have been shown to cause KCC2 dysfunction in adult spinal cord through brain-derived neurotrophic factor (BDNF) signaling, which switches the hyperpolarizing inhibitory transmission to be depolarizing and excitatory. However, the mechanisms by which BDNF impairs KCC2 function remain to be elucidated. Here we found that BDNF treatment enhanced KCC2 ubiquitination in the dorsal horn of adult mice, a post-translational modification that leads to KCC2 degradation. Our data showed that spinal BDNF application promoted KCC2 interaction with Casitas B-lineage lymphoma b (Cbl-b), one of the E3 ubiquitin ligases that are involved in the spinal processing of nociceptive information. Knockdown of Cbl-b expression decreased KCC2 ubiquitination level and attenuated the pain hypersensitivity induced by BDNF. Spared nerve injury significantly increased KCC2 ubiquitination, which could be reversed by inhibition of TrkB receptor. Our data implicated that KCC2 was one of the important pain-related substrates of Cbl-b and that ubiquitin modification contributed to BDNF-induced KCC2 hypofunction in the spinal cord.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Hiperalgesia/patologia , Proteínas Proto-Oncogênicas c-cbl/metabolismo , Corno Dorsal da Medula Espinal/patologia , Simportadores/metabolismo , Proteínas Adaptadoras de Transdução de Sinal/genética , Animais , Modelos Animais de Doenças , Técnicas de Silenciamento de Genes , Humanos , Hiperalgesia/etiologia , Masculino , Camundongos , Células do Corno Posterior/metabolismo , Proteólise , Proteínas Proto-Oncogênicas c-cbl/genética , Transdução de Sinais , Corno Dorsal da Medula Espinal/citologia , Ubiquitinação , Cotransportadores de K e Cl-
2.
Eur J Pharmacol ; 899: 174034, 2021 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-33727056

RESUMO

Glycine receptor is one of the chloride-permeable ion channels composed of combinations of four α subunits and one ß subunit. In adult spinal cord, the glycine receptor α1 subunit is crucial for the generation of inhibitory neurotransmission. The reduced glycinergic inhibition is regarded as one of the key spinal mechanisms underlying pathological pain symptoms. However, the expression and function of glycine receptors in the peripheral system are largely unknown as yet. Here we found that glycine receptor α1 subunit was prevalent in the dorsal root ganglia (DRG) neurons as well as in the sciatic nerves of adult mice. Intraganglionar or intraplantar injection of glycine receptor antagonist strychnine caused the hypersensitivity to mechanical, thermal and cold stimuli, suggesting the functional importance of peripheral glycine receptors in the control of nociceptive signal transmission. Our data showed that peripheral inflammation induced by formalin decreased the expression of glycine receptor α1 subunit on the plasma membrane of DRG neurons, which was attributed to the activation of protein kinase C signaling. Intraplantar application of glycine receptor agonist glycine or positive modulator divalent zinc ion alleviated the first-phase painful behaviors induced by formalin. These data suggested that peripheral glycine receptor might serve as an effective target for pain therapy.


Assuntos
Gânglios Espinais/metabolismo , Inibição Neural , Dor Nociceptiva/metabolismo , Receptores de Glicina/metabolismo , Analgésicos/farmacologia , Animais , Comportamento Animal , Modelos Animais de Doenças , Formaldeído , Gânglios Espinais/efeitos dos fármacos , Gânglios Espinais/fisiopatologia , Glicinérgicos/farmacologia , Masculino , Camundongos , Atividade Motora , Inibição Neural/efeitos dos fármacos , Nociceptividade , Dor Nociceptiva/induzido quimicamente , Dor Nociceptiva/fisiopatologia , Dor Nociceptiva/prevenção & controle , Limiar da Dor/efeitos dos fármacos , Proteína Quinase C/metabolismo , Receptores de Glicina/antagonistas & inibidores , Transdução de Sinais
3.
Sci Signal ; 13(638)2020 06 30.
Artigo em Inglês | MEDLINE | ID: mdl-32606037

RESUMO

N-methyl-d-aspartate (NMDA) glutamate receptors (NMDARs) containing GluN2B subunits are prevalent early after birth in most brain regions in rodents. Upon synapse maturation, GluN2B is progressively removed from synapses, which affects NMDAR function and synaptic plasticity. Aberrant recruitment of GluN2B into mature synapses has been implicated in several neuropathologies that afflict adults. We found that the E3 ubiquitin ligase Cbl-b was enriched in the spinal cord dorsal horn neurons of mice and rats and suppressed GluN2B abundance during development and inflammatory pain. Cbl-b abundance increased from postnatal day 1 (P1) to P14, a critical time period for synapse maturation. Through its N-terminal tyrosine kinase binding domain, Cbl-b interacted with GluN2B. Ubiquitination of GluN2B by Cbl-b decreased the synaptic transmission mediated by GluN2B-containing NMDARs. Knocking down Cbl-b in vivo during P1 to P14 led to sustained retention of GluN2B at dorsal horn synapses, suggesting that Cbl-b limits the synaptic abundance of GluN2B in adult mice. However, peripheral inflammation induced by intraplantar injection of complete Freund's adjuvant resulted in the dephosphorylation of Cbl-b at Tyr363, which impaired its binding to and ubiquitylation of GluN2B, enabling the reappearance of GluN2B-containing NMDARs at synapses. Expression of a phosphomimic Cbl-b mutant in the dorsal horn suppressed both GluN2B-mediated synaptic currents and manifestations of pain induced by inflammation. The findings indicate a ubiquitin-mediated developmental switch in NMDAR subunit composition that is dysregulated by inflammation, which can enhance nociception.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Nociceptividade , Proteínas Proto-Oncogênicas c-cbl/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Corno Dorsal da Medula Espinal/metabolismo , Sinapses/metabolismo , Ubiquitinação , Animais , Masculino , Camundongos , Dor/metabolismo , Dor/patologia , Ratos , Ratos Sprague-Dawley , Corno Dorsal da Medula Espinal/patologia , Sinapses/patologia
4.
Neuropharmacology ; 176: 108219, 2020 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-32579955

RESUMO

Glycine receptor α1ins subunit is located at inhibitory synapses in the superficial dorsal horn of adult spinal cord and is engaged in the glycinergic inhibition of nociceptive neuronal excitability and transmission. The α1ins phosphorylation at Ser380 by extracellular signal-regulated kinase (ERK) has been shown to decrease glycinergic synaptic currents and contribute to spinal disinhibition. Here we found that peripheral inflammation induced by Complete Freund's Adjuvant increased Ser380 phosphorylation in spinal cord dorsal horn of mice, which was repressed by specific activation of adenosine A1 receptor (A1R). Protein phosphatase-1 (PP1), a ubiquitously-distributed serine/threonine phosphatase, was required for A1R to reduce Ser380 phosphorylation. Our data showed that Gßγ dimer, when released after activation of Gi protein-coupled A1R, interacted with PP1 and directed this phosphatase to α1ins, allowing for the full dephosphorylation of Ser380 residue. Sequestration of Gßγ dimer by viral expression of the C-terminal tail of ß-adrenergic receptor kinase (ßARKct) dissociated PP1 from α1ins complex, leading to robust Ser380 phosphorylation. Meanwhile, Gßγ inhibition compromised the ability of A1R to alleviate inflammatory pain. The inhibitory effect of A1R on Ser380 phosphorylation was also attributed to the inactivation of ERK in CFA mice. Our data thus identified glycine receptor α1ins subunit as an important target for adenosinergic suppression of inflammatory pain.


Assuntos
Analgesia/métodos , Receptor A1 de Adenosina/metabolismo , Receptores de Glicina/metabolismo , Corno Dorsal da Medula Espinal/metabolismo , Adenosina/farmacologia , Agonistas do Receptor A1 de Adenosina/farmacologia , Animais , Relação Dose-Resposta a Droga , Adjuvante de Freund/toxicidade , Células HEK293 , Humanos , Masculino , Camundongos , Dor/induzido quimicamente , Dor/metabolismo , Medição da Dor/efeitos dos fármacos , Medição da Dor/métodos , Fosforilação/efeitos dos fármacos , Fosforilação/fisiologia , Corno Dorsal da Medula Espinal/química , Corno Dorsal da Medula Espinal/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA